Skip to main content
Opens in new window
NHS Wales
Skip Navigation
Feedback
Cymraeg
Cymraeg
All...
Search
NHS Wales Joint Commissioning Committee
Cymraeg
Cymraeg
Search
Menu
Home
About Us
Show Submenu For About Us
Where We Are
Our Team
Join Our Team
Regulations
Directions
Standing Orders
Standing Financial Instructions
Memorandum of Agreement
Hosting Agreement
The Committee
Show Submenu For The Committee
Committee Members
Committee Secretary
Committee Meeting Notice
Committee Meeting Papers
Quality, Safety and Outcomes Sub-Committee
Planning Performance and Finance Sub-Committee
Register of Interests
Accountability Report
Legacy EASC Committee (Archive)
Legacy WHSSC Committee (Archive)
Our Structure
Show Submenu For Our Structure
Chief Commissioner
Ambulance Services and 111
Corporate Planning and Strategy
Finance and Value
Medical Directorate
Nursing and Quality Assurance
Specialist Mental Health, Learning Disabilities and Vulnerable Groups
Specialised Services
InsightHub
Show Submenu For InsightHub
Ambulance Service Indicators
NHS 111 Wales Press 2: Mental Health Support
Performance Report
Publications
Clinical Policies
Show Submenu For Clinical Policies
Cancer and Blood
Cardiac and Thoracic
Children Services
Fertility
Gender
Genomics
Trauma and Critical Care
Mental Health
Neurosciences
Plastic Surgery and Burns
Posture and Mobility
Rare Diseases
Welsh Kidney Network
Other
Engagement
Show Submenu For Engagement
EMRTS Service Review Engagement 2023
NHS Wales Specialist Children and Young People Gender Identity Services
Contact us
Show Submenu For Contact us
SAFER Guidance
Freedom of Information
More
×
NHS Wales
Feedback
All...
Search
Listen
Home
›
Clinical Policies
›
Other
Other
Hyperbaric Oxygen Therapy, Commissioning Policy (CP07), July 2023.pdf
13 October 2025
Hyperbaric Oxygen Therapy, Commissioning Policy (CP07), July 2023.pdf (
PDF, 363Kb
)
New Treatment Fund, (CP159), January 2025.pdf
7 January 2026
New Treatment Fund, (CP159), January 2025.pdf (
PDF, 354Kb
)
Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations, (PP196), March 2020.pdf
13 October 2025
Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations, (PP196), March 2020.pdf (
PDF, 277Kb
)